PDLI : Summary for PDL BioPharma, Inc. - Yahoo Finance

U.S. Markets closed

PDL BioPharma, Inc. (PDLI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.27-0.04 (-1.73%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close2.31
Bid2.21 x 200
Ask2.35 x 200
Day's Range2.25 - 2.32
52 Week Range1.93 - 3.84
Avg. Volume2,422,442
Market Cap375.78M
PE Ratio (TTM)2.15
Earnings DateN/A
Dividend & Yield0.20 (8.81%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire3 days ago

    PDL BioPharma to Present at the 2017 RBC Capital Markets Global Healthcare Conference

    INCLINE VILLAGE, Nev., Feb. 17, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (PDLI) today announced that John P. McLaughlin, PDL's president and chief executive officer, will participate in a fireside chat at the 2017 RBC Capital Markets Global Healthcare Conference next week in New York. To access the live and subsequently archived webcast of the presentation, go to the company's website at http://www.pdl.com and go to "Presentations and Events." Please connect to the website at least 15 minutes prior to the presentation to allow for any software download that may be necessary. The archived webcast will be available for at least seven days following the presentation.

  • Kiplinger4 days ago

    9 Top Pharmaceutical Stocks to Buy for the Dividends

    When investors are on the hunt for income-driving dividend stocks, they often gravitate toward utilities or consumer staples names. Conversely, pharmaceutical stocks are rarely seen as effective dividend stocks. Although drugs are also relatively non-cyclical, these stocks are often impacted by an ever-changing regulatory environment and the ever-changing strength or weakness of a drugmaker's portfolio and pipeline.

  • Accesswire20 days ago

    PDL BioPharma Inc. Review of 3Q 2016 Results and Forward Outlook

    NEW YORK, NY / ACCESSWIRE / January 31, 2017 / Traders News Source, an equity research firm specializing in small and micro-cap securities, is looking at recent events with PDL BioPharma Inc. (NASDAQ: ...